How to Raise Money for Your Medtech Startup | Christina Goudy
In this episode of LifeSci Continuum, I sit down with Christina Goudy, MBA, CEO and co-founder of Reach Orthopaedics, to talk about what medtech fundraising actually looks like in the real world.
Christina is building a company in a tough category, solving a real orthopedic problem, raising capital in a brutal market, and doing it all from Canada while navigating the U.S. medtech investment landscape.
We get into medical device startup fundraising, pitch storytelling, investor expectations, startup marketing, cross-border investment, and why founders need to act like real companies earlier.
A lot of medtech founders still assume that if the science is strong enough, the market, investors, and momentum will eventually line up.
Nice fantasy. Not how this works.
In this conversation, Christina breaks down what it looks like to raise money for an early-stage medical device company when the funding market changes, investor expectations shift, and the original plan no longer fits. We discussed how Reach Orthopaedics moved from a priced round to a SAFE, why adapting the structure of the raise matters, and how founders need to think about dilution, milestones, and what investors need to believe before they move.
One of the most useful parts of this episode is investor pitch storytelling. Christina explains how her team reworked the story to make the problem resonate clearly, especially with investors who do not live in orthopedic surgery every day. A lot of founders are still pitching like technical insiders to audiences who are not. They lead with jargon, features, and science details when what they really need to do first is create relevance, context, and urgency.
We also get into something founders do not talk about enough: marketing in early-stage medtech startups. Christina makes the point that marketing is not a luxury you get around to after the “real work” is done. Fundraising is marketing. Investor confidence is shaped by how credible, clear, and coherent your company looks. Your website, story, identity, positioning, and ability to explain the problem and your value are all doing work long before revenue shows up. If you still think branding and messaging are optional because you are “science first,” this episode may irritate you a little. Good.
Another useful angle is the Canadian medtech startup perspective. Christina shares the real friction of trying to raise from U.S. investors when some funds want a company incorporated in the U.S. before they will even engage. That is one of those practical, expensive startup realities that can eat time and money fast. It is also a good reminder that raising capital is not just about the pitch. It is about structure, geography, timing, investor fit, and knowing which constraints matter.
We also touch on accelerator programs, startup cash flow, team leverage, and why employees inside early-stage startups often have to build the roadmap while walking it. Christina has a refreshingly honest take on why founders need to listen when team members advocate for themselves. In startups, replacing someone is not just replacing a headcount. It is replacing hard-earned navigation through a messy system without a template.
If you are building a medical device company, trying to improve your medtech fundraising strategy, reworking your startup pitch deck, or figuring out how to communicate real value to investors without burying them in technical detail, this episode is worth your time.
Follow Bill: / founderandcdo
Contact Bill: https://meshagency.com/lets-connect/
Video Podcast: / @billschickfcmo
Audio Podcast: https://www.buzzsprout.com/2380430/episodes/19108692
Follow Christina: / christina-goudy